Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.36 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.36 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.34 |
| ▸ | MTNR1A | P48039 | 11/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 11/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.33 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7734700 | 0.95 | NLRP3 (0.35) | NLRP3PTK2AKR1B1MTNR1AMTNR1B | |
| SCHEMBL7734093 | 0.91 | SIRT2 (0.37) | AKR1B1SIRT2MTNR1AMTNR1BMAPT | |
| SCHEMBL7734231 | 0.88 | RAB9A (0.40) | SIRT2L3MBTL1SSTR2SSTR4 | |
| SCHEMBL7734855 | 0.88 | SIRT2 (0.34) | AKR1B1SIRT2MTNR1AMTNR1B | |
| SCHEMBL7734848 | 0.88 | MAPT (0.38) | AKR1B1SIRT2MAPT | |
| SCHEMBL7733875 | 0.87 | LMNA (0.41) | AKR1B1SIRT2MTNR1AMTNR1BLMNA | |
| SCHEMBL7733869 | 0.86 | MTNR1A (0.46) | PTK2MTNR1AMTNR1B | |
| SCHEMBL7734094 | 0.85 | MEN1 (0.39) | NLRP3PTK2MTNR1AMTNR1BLMNA | |
| SCHEMBL7735189 | 0.83 | GAA (0.36) | SIRT2L3MBTL1MAPT | |
| SCHEMBL7735795 | 0.83 | MAPT (0.45) | SIRT2L3MBTL1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6372770-B1 | TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF | EURO-CELTIQUE, S.A. | 2002-04-16 | — | — | US | claimed |
| US-6372770-B1 | TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF | EURO-CELTIQUE, S.A. | 2002-04-16 | — | — | US | disclosed |